Published in Women's Health Weekly, October 19th, 2006
Since secondary tumors, ignited by spreading malignant cells, and not the primary breast cancer tumor, are the primary cause of cancer death, early detection of metastatic spread is crucial to a woman's prognosis.
It should enable the patient's doctor to adjust the woman's treatment so that it will target the spreading cancer early, said Winfried H. Albert, Ph.D., chief scientific officer of AdnaGen.
Albert said that the company's diagnostic tool, which is being evaluated in clinical studies at The University of Texas M. D. Anderson...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.